NSE ScannerComparison · NSE · data 2026-11-01
Procter & Gamble Health Ltd. vs Strides Pharma Science Ltd
In plain words
Size: Strides Pharma Science Ltd is about 1 times the market value of Procter & Gamble Health Ltd..
Valuation (P/E): Procter & Gamble Health Ltd. 28.8 vs Strides Pharma Science Ltd 16.
Return on equity: Procter & Gamble Health Ltd. 61.6% vs Strides Pharma Science Ltd 19.7%.
Debt to equity: Strides Pharma Science Ltd 0.57 vs Procter & Gamble Health Ltd. 0.02.
Differences in the numbers, not a recommendation of either stock.
Side by side
| PGHL | STAR | |
|---|---|---|
| Price | ₹5,670.5 | ₹1,068.8 |
| Market cap | ₹9,436 cr | ₹9,855 cr |
| P/E | 28.8 | 16 |
| P/B | 17.9 | 2.9 |
| ROE | 61.6% | 19.7% |
| ROCE | 75.7% | 15.1% |
| Debt / equity | 0.02 | 0.57 |
| Operating margin | 30.8% | 14.2% |
| Dividend yield | 2.73% | 0.47% |
| Sales growth, 3 years (yearly) | 8.2% | 9.2% |
| Profit growth, 3 years (yearly) | 19.3% | — |
| 1-year return | -8.3% | 24.7% |
| Revenue, last 12 months | ₹1,408 cr | ₹5,213 cr |
| Net profit, last 12 months | ₹327 cr | ₹617 cr |
| Latest quarter | Jun 2026 | Sept 2026 |
| Quarter net profit | ₹96 cr | ₹131 cr |
| Quarter profit vs a year earlier | +45.3% | +2.6% |
| Promoter holding | 51.82% | 29.00% |
| Health check | Strong (7.6/10) | Strong (7.5/10) |
Common questions
Which has a higher P/E, Procter & Gamble Health Ltd. or Strides Pharma Science Ltd?
Procter & Gamble Health Ltd. trades at the higher P/E (28.8 against 16). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Procter & Gamble Health Ltd. (61.6% against 19.7%).
Which carries more debt?
Strides Pharma Science Ltd has the higher debt-to-equity ratio (0.57 against 0.02).